Latest Cancer News

Interim Results of X-396 in ALK positive Non-Small Cell Lung Cancer Appear Promising (08-29-2014)
Preliminary results from a small phase 1 study of X-396, a novel anaplastic lymphoma kinase (ALK) inhibitor showed that X-396 is well tolerated and has antitumor activity in patients with ALK positive... Continue Reading

Risk of Breast Cancer Recurrence Doesn’t Increase with TNF Inhibitor Use (08-28-2014)
According to the results of a recently published study from Swedish investigators treatment with tumor necrosis factor inhibitors (TNF) does not appear to increase the rate of breast cancer recurrence... Continue Reading

Advaxis and Merck Form Collaboration to Evaluate Investigational Combination of Two Novel Immunotherapy Candidates for Advanced Prostate Cancer (08-27-2014)
Advaxis, Inc.a clinical-stage biotechnology company developing cancer immunotherapies, has entered into a clinical trial collaboration agreement with Merck to evaluate the safety and efficacy of ADXS-PSA... Continue Reading

More Cancer News

Locations

 
Jackson
322 Hospital Boulevard
Jackson, TN 38305
731-668-1668
800-870-5471
 
 
Dyersburg
440 Wilkinson Drive
Dyersburg, TN 38024
731 285-2211
888-748-8511
 
 
Paris
1290 Kelley Drive
Paris, TN 38242
731-644-3522
800-221-0948
 
 
Union City
1209 Reelfoot Ave.
Union City, TN 38261
731-884-8611
888-941-8611
 
 
Hematology/Oncology:
1720 Reelfoot Ave. Ste 205
Union City, TN 38261
731-884-3895